Home > Insider Trading > Filing (0000904454-14-000793)

Filing Details

Accession Number:: 0000904454-14-000793
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-10 21:13:04
Reporting Period:: 2014-12-08

Filing Date:: 2014-12-10
Accepted Time:: 2014-12-10 21:13:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404644	Aquinox Pharmaceuticals Inc	AQXP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
200406	Johnson & Johnson	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		No	No	Yes	No
924020	Johnson & Johnson Development Corp Et Al	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-08	2,000	$7.69	1,361,494	No	4	S	Indirect	Johnson & Johnson Development Corporation
Common Stock	Disposition	2014-12-09	5,000	$7.73	1,356,494	No	4	S	Indirect	Johnson & Johnson Development Corporation
Common Stock	Disposition	2014-12-10	1,300	$7.70	1,355,194	No	4	S	Indirect	Johnson & Johnson Development Corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Johnson & Johnson Development Corporation
No	4	S	Indirect	Johnson & Johnson Development Corporation
No	4	S	Indirect	Johnson & Johnson Development Corporation

Footnotes

The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $7.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.